Download Full Publication: In-Line Filtration Reduces Postoperative Venous Peripheral Phlebitis Associated With Cannulation: A Randomized Clinical Trial

Villa G. et al. Anesth Analg. 2018

"The Incidence of Phlebitis within the 48 postoperative hours was much lower in the In-Line Filter group than in the No-Filter group (2.2% vs 26.87%; P < .001)"

DOWNLOAD FULL PUBLICATION: Villa G. et al., Anesth Analg. 2018, In-Line Filtration Reduces Postoperative Venous Peripheral Phlebitis Associated With Cannulation: A Randomized Clinical Trial.

By clicking the Submit button below and proceeding I confirm that I have reviewed and agree with the Terms of Use and the Privacy Policy.


  • Study Background:
    Peripheral venous cannulation is an everyday practice of care for patients undergoing anesthesia and surgery. Particles infused with intravenous fluids (eg, plastic/glass/drug particulates) contribute to the pathogenesis of peripheral phlebitis. The aim of this study is to demonstrate the efficacy of in-line filtration in reducing the incidence of postoperative phlebitis associated with peripheral short-term vascular access.
  • Methods:
    In this controlled trial, 268 surgical patients were randomly assigned to in-line filtration and standard care (NCT03193827). The incidence of phlebitis (defined as visual infusion phlebitis [VIP] score, ≥2) within 48 hours was compared between the 2 groups, as well as the onset and severity of phlebitis and the reasons for removal of the cannula. The lifespan of venous cannulae was compared for the in-line filter and no-filter groups through a Kaplan-Meier curve.
  • Conclusions:
    The authors concluded In-Line Filtration has a protective effect for postoperative phlebitis and prolongs cannula lifespan during peripheral venous cannulation in surgical patients.

About Pall Medical

 

Pall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with medical customers to advance health, safety and environmentally responsible technologies. In 2009, the Health Information Technology for Economic and Clinical Health (HITECH) Act was passed. The purpose of this act was to facilitate the use of technology, and specifically electronic information exchange within the medical industry.  HITECH created an onslaught of complicated regulations and industrial demands., but Pall was there to assist customers through this process from the very beginning. 

 

 

 

Recognized Industry Leadership

Pall Corporation - Medical

Pall Corporation, 25 Harbor Park Dr, Port Washington, NY 11050 | Tel: 1-516-484-3600 | www.pall.com/medical

 

© 2018, Pall Corporation, the Pall logo are trademarks of Pall Corporation.